Trombopag 50mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Eltrombopag (50mg)
Overview Trombopag 50mg Tablet
Fifty-milligram Trombopag tablets address low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP), or chronic hepatitis C (HCV) infection, and severe aplastic anemia. This thrombopoietin receptor agonist promotes platelet production, thus aiding in bleeding control. Adhere strictly to your physician's prescribed dosage and regimen. Administration is possible on an empty stomach; swallow the tablet whole – do not crush, chew, or break it. Report any medication allergies to your doctor. Commonly reported side effects encompass nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Should these effects prove troublesome, consult your doctor for potential symptom management strategies. Prior to commencing treatment, disclose any pre-existing health conditions and all concurrent medications. Liver impairment may necessitate dosage adjustments; inform your doctor accordingly.
Primary Ingredients of Trombopag 50mg Tablet
No text provided to rephrase.
Uses of Trombopag 50mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; management of critical bone marrow failure.
Major Benefits of Trombopag 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Trombopag 50mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume it on an empty stomach.
Common Side effects of Trombopag 50mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Trombopag 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trombopag 50mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Trombopag 50mg Tablet works:
Platelet production is boosted by the thrombopoietin receptor agonist, Trombopag 50mg Tablet. This medication increases the blood's platelet count, thereby lessening the risk of, or stopping, hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Trombopag 50mg Tablet and alcohol is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Trombopag 50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Trombopag 50mg tablets is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Trombopag 50mg Tablet, which can induce dizziness and reduced alertness, among other side effects.
KidneySAFE IF PRESCRIBED
Trombopag 50mg tablets are considered safe for patients with kidney disease; dosage modification is not typically necessary. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function during treatment is advisable.
LiverCAUTION
Patients with liver impairment should use Trombopag 50mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Trombopag 50mg Tablet :
Omit any missed Trombopag 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Trombopag 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Thrombopoietin receptor activator |

